Health · 28 views
Lower dementia risk seen with sodium-glucose cotransporter 2 in seniors 65+ with mood, psychotic disorders
Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is associated with a lower risk for dementia in older adults with mood and psychotic disorders, according to a study published online June 30 in JAMA Network Open.
AI Summary
Research has identified a potential link between the use of sodium-glucose cotransporter 2 inhibitors and a reduced risk of dementia in seniors aged 65 and older who also have mood or psychotic disorders. The study, which was published in JAMA Network Open, found that individuals in this demographic who used these inhibitors experienced a lower risk of dementia compared to those who did not use them.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Recommendations updated for management of anemia in chronic kidney diseaseContinue reading
- First dual-target high-intensity focused ultrasound procedure for people with advanced Parkinson's diseaseContinue reading
- IASLC tumor budding grade identifies high-risk patients with resected lung squamous cell carcinomaContinue reading
- 252 million young children in developing countries are undernourished, multidimensionally poor, new global study findsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow